AU2019902006A0 - Prevention of infection by highly pathogenic viruses using topical application of povidone-iodine on mucous membranes - Google Patents
Prevention of infection by highly pathogenic viruses using topical application of povidone-iodine on mucous membranesInfo
- Publication number
- AU2019902006A0 AU2019902006A0 AU2019902006A AU2019902006A AU2019902006A0 AU 2019902006 A0 AU2019902006 A0 AU 2019902006A0 AU 2019902006 A AU2019902006 A AU 2019902006A AU 2019902006 A AU2019902006 A AU 2019902006A AU 2019902006 A0 AU2019902006 A0 AU 2019902006A0
- Authority
- AU
- Australia
- Prior art keywords
- povidone
- iodine
- infection
- prevention
- topical application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 title 1
- 210000004400 Mucous Membrane Anatomy 0.000 title 1
- 229920000153 Povidone-iodine Polymers 0.000 title 1
- 241000700605 Viruses Species 0.000 title 1
- 201000009910 diseases by infectious agent Diseases 0.000 title 1
- 230000001717 pathogenic Effects 0.000 title 1
- 229960001621 povidone-iodine Drugs 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 230000000699 topical Effects 0.000 title 1
Priority Applications (16)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021555886A JP2022538711A (en) | 2019-06-10 | 2020-06-10 | Prevention of infection by highly pathogenic viruses using topical application of povidone-iodine to mucous membranes |
| BR112021024916A BR112021024916A2 (en) | 2019-06-10 | 2020-06-10 | Prevention of infection with highly pathogenic viruses using topical application of povidone-iodine to mucous membranes |
| PCT/AU2020/050586 WO2020232515A1 (en) | 2019-06-10 | 2020-06-10 | Prevention of infection by highly pathogenic viruses using topical application of povidone-iodine on mucous membranes |
| CA3141483A CA3141483A1 (en) | 2019-06-10 | 2020-06-10 | Prevention of infection by highly pathogenic viruses using topical application of povidone-iodine on mucous membranes |
| MX2021015110A MX2021015110A (en) | 2019-06-10 | 2020-06-10 | Prevention of infection by highly pathogenic viruses using topical application of povidone-iodine on mucous membranes. |
| KR1020227000461A KR20220018570A (en) | 2019-06-10 | 2020-06-10 | Prevention of infection caused by highly pathogenic viruses by topical application of povidone-iodine to the mucous membranes |
| CN202080042482.0A CN114258303A (en) | 2019-06-10 | 2020-06-10 | Prevention of highly pathogenic viral infections using topical application of povidone-iodine to mucous membranes |
| EP20809730.3A EP3980031A4 (en) | 2019-06-10 | 2020-06-10 | Prevention of infection by highly pathogenic viruses using topical application of povidone-iodine on mucous membranes |
| SG11202112735QA SG11202112735QA (en) | 2019-06-10 | 2020-06-10 | Prevention of infection by highly pathogenic viruses using topical application of povidone-iodine on mucous membranes |
| AU2020280226A AU2020280226A1 (en) | 2019-06-10 | 2020-06-10 | Prevention of infection by highly pathogenic viruses using topical application of povidone-iodine on mucous membranes |
| US16/925,740 US11246887B2 (en) | 2019-06-10 | 2020-07-10 | Prevention of infection by highly pathogenic viruses using topical application of povidone-iodine on mucous membranes |
| ZA2021/09360A ZA202109360B (en) | 2019-06-10 | 2021-11-22 | Prevention of infection by highly pathogenic viruses using topical application of povidone-iodine on mucous membranes |
| CL2021003208A CL2021003208A1 (en) | 2019-06-10 | 2021-12-02 | Prevention of highly pathogenic virus infections by topical application of povidone-iodine on mucous membranes |
| IL288742A IL288742A (en) | 2019-06-10 | 2021-12-07 | Prevention of infection by highly pathogenic viruses using topical application of povidone-iodine on mucous membranes |
| US17/544,926 US11969441B2 (en) | 2019-06-10 | 2021-12-07 | Prevention of infection by highly pathogenic viruses using topical application of povidone-iodine on mucous membranes |
| US17/544,931 US20220088067A1 (en) | 2019-06-10 | 2021-12-07 | Prevention of infection by highly pathogenic viruses using topical application of povidone-iodine on mucous membranes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2019902006A0 true AU2019902006A0 (en) | 2019-06-27 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3980031A4 (en) | Prevention of infection by highly pathogenic viruses using topical application of povidone-iodine on mucous membranes | |
| EP3996716A4 (en) | Compounds useful to treat influenza virus infections | |
| EP4265299A3 (en) | Therapeutic compounds useful for the prophylactic or therapeutic treatment of an hiv virus infection | |
| EP3474861A4 (en) | Compositions comprising hmos, their production and use for the prevention and/or treatment of viral and/or bacterial infections | |
| BR112017011478A2 (en) | antibody-antibiotic conjugate compound, antibody-antibiotic conjugate, pharmaceutical composition, methods of treating a bacterial infection and exterminating staph aureus, process for compound preparation, kit and antibiotic-binder intermediate | |
| EP3846616A4 (en) | Cannabinoids for the treatment of gram-positive infections including antibiotic-resistant bacterial strains | |
| CA3010327A1 (en) | Aryl substituted pyrimidines for use in influenza virus infection | |
| WO2010095041A3 (en) | Compositions, methods, and kits for treating influenza viral infections | |
| EP3423075A4 (en) | Stapled intracellular-targeting antimicrobial peptides to treat infection | |
| EP3941501A4 (en) | Topical croton lechleri compositions for the treatment of acute bacterial skin or skin structure infection | |
| EP3906025A4 (en) | Topical formulations having cannabinoid | |
| EP4097620A4 (en) | Privacy-preserving signature | |
| MX2019011908A (en) | Anti-bacterial peptide macrocycles and use thereof. | |
| AU2019902006A0 (en) | Prevention of infection by highly pathogenic viruses using topical application of povidone-iodine on mucous membranes | |
| AU2018902045A0 (en) | Prevention of infection by highly pathogenic viruses using topical application of povidone-iodine on mucous membranes | |
| AU2018901988A0 (en) | Prevention of infection by highly pathogenic viruses using topical application of povidone-iodine on mucous membranes | |
| AU2020900489A0 (en) | Prevention of infection by highly pathogenic viruses using topical application of povidone-iodine on mucous membranes | |
| AU2017902102A0 (en) | Prevention of infection by highly pathogenic viruses using topical application of povidone-iodine on mucous membranes | |
| AU2018257122A1 (en) | Pharmaceutical composition comprising attenuated streptococcus pneumoniae strains and use thereof | |
| AU2016902095A0 (en) | Prevention of infection by highly pathogenic viruses using topical application of povidone-iodine on mucous membranes | |
| EP4146227A4 (en) | Treatment of viral infections | |
| EP4119163A4 (en) | Viral infection therapeutic | |
| EP4065106A4 (en) | Methods of treating hiv-1 infection | |
| EP3996743A4 (en) | Engineered vaccinia virus | |
| EP3978026A4 (en) | Use of anthocyanin-anionic polysaccharide complex for preventing or treating influenza virus a infection |